drug-drug-interaction-analysis

To check drug-drug interactions using KEGG, provide a list of up to five medication names. The tool resolves these names to KEGG IDs, queries the DDI database, and returns structured interaction details including severity, mechanism, and CYP involvement.

A polypharmacy safety review for drug interactions includes severity levels, underlying mechanisms, and CYP enzyme involvement. It evaluates up to five concurrent medications to support clinical decisions by aggregating interaction context from the KEGG database.

No, you cannot analyze more than five drugs in a single interaction check. The tool is specifically designed to process a maximum of five medications per query to ensure accurate DDI resolution and KEGG API retrieval.

CYP enzyme involvement is a core component of the drug interaction data returned. The analysis highlights specific CYP-mediated mechanisms to help identify metabolic competition or inhibition within your polypharmacy regimen.

The tool works directly with standard drug names. It automatically resolves your provided medication names into the required KEGG IDs before querying the DDI API, so you do not need to supply specific identifiers manually.

The best way to use DDI analysis for pre-prescription clinical checks is to input the proposed medication regimen of up to five drugs. The tool evaluates interaction severity and mechanisms to inform clinical decision-support workflows before prescribing.